• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉减少症会损害肝硬化患者的健康相关生活质量。

Sarcopenia impairs health-related quality of life in cirrhotic patients.

机构信息

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Eur J Gastroenterol Hepatol. 2019 Dec;31(12):1550-1556. doi: 10.1097/MEG.0000000000001472.

DOI:10.1097/MEG.0000000000001472
PMID:31206408
Abstract

AIM

Sarcopenia is associated with poor health-related quality of life (HRQOL) in the general population. However, in cirrhotic patients, as the development of sarcopenia is closely related to declined liver function, which also impairs HRQOL, whether sarcopenia deteriorates HRQOL independently from declined liver function remains unclear. The aim of this study was to clarify the impact of sarcopenia on HRQOL impairment in cirrhotic patients.

PATIENTS AND METHODS

A total of 88 cirrhotic patients [median age, 69 years; range: 31-79 years; 49 male (55.7%), 45 with hepatocellular carcinoma (51.1%)] were analyzed. We measured HRQOL using the 36-item Short-Form Health Survey version 2 questionnaire and identified factors contributing to scores lower than 50 in physical component summary (PCS), mental component summary, and role-social component summary (RCS) scores.

RESULTS

Twenty-four (27.2%) patients had sarcopenia. PCS and RCS scores were significantly lower in patients with sarcopenia compared with those without sarcopenia. Patients with Child-Pugh (CP) classification B or C showed significantly lower scores in PCS and RCS than those with CP classification A. On multivariate analysis, the presence of sarcopenia was the only factor associated with low PCS scores [odds ratio (OR): 11.6; P = 0.031]. Female sex (OR: 3.34; P = 0.034), CP classification B or C (OR: 3.19; P = 0.037), and presence of sarcopenia (OR: 4.64; P = 0.016) were identified as independent factors for low RCS scores.

CONCLUSION

Sarcopenia independently impairs physical and role-social HRQOL in cirrhotic patients.

摘要

目的

在普通人群中,肌肉减少症与健康相关生活质量(HRQOL)较差相关。然而,在肝硬化患者中,由于肌肉减少症的发展与肝功能下降密切相关,而肝功能下降也会损害 HRQOL,因此肌肉减少症是否独立于肝功能下降而进一步恶化 HRQOL尚不清楚。本研究旨在阐明肌肉减少症对肝硬化患者 HRQOL 损害的影响。

患者与方法

共分析了 88 例肝硬化患者[中位年龄 69 岁;范围:31-79 岁;49 名男性(55.7%),45 名患有肝细胞癌(51.1%)]。我们使用 36 项简短健康调查量表 2 版本问卷测量 HRQOL,并确定导致生理成分综合评分(PCS)、心理成分综合评分和角色-社会成分综合评分(RCS)评分低于 50 的因素。

结果

24 例(27.2%)患者患有肌肉减少症。与无肌肉减少症的患者相比,有肌肉减少症的患者的 PCS 和 RCS 评分显著降低。CP 分级为 B 或 C 的患者的 PCS 和 RCS 评分明显低于 CP 分级为 A 的患者。多变量分析显示,存在肌肉减少症是导致低 PCS 评分的唯一因素[比值比(OR):11.6;P = 0.031]。女性(OR:3.34;P = 0.034)、CP 分级 B 或 C(OR:3.19;P = 0.037)和存在肌肉减少症(OR:4.64;P = 0.016)是 RCS 评分较低的独立因素。

结论

肌肉减少症独立损害肝硬化患者的生理和角色-社会 HRQOL。

相似文献

1
Sarcopenia impairs health-related quality of life in cirrhotic patients.肌肉减少症会损害肝硬化患者的健康相关生活质量。
Eur J Gastroenterol Hepatol. 2019 Dec;31(12):1550-1556. doi: 10.1097/MEG.0000000000001472.
2
Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.严重的肌肉消耗预测术后住院时间,但与肝移植后的生存率无关。
Liver Transpl. 2014 Jun;20(6):640-8. doi: 10.1002/lt.23863. Epub 2014 Mar 26.
3
Associations between the Severity of Sarcopenia and Health-Related Quality of Life in Community-Dwelling Middle-Aged and Older Adults.社区中老年居民肌少症严重程度与健康相关生活质量的关系。
Int J Environ Res Public Health. 2021 Jul 29;18(15):8026. doi: 10.3390/ijerph18158026.
4
Health-related quality of life in cirrhotic patients: a case-control study.
Tunis Med. 2019 Aug-Sep;97(8-9):990-996.
5
Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature.慢性终末期肝脏疾病中的肌肉减少症:文献的性别导向分析。
Dig Liver Dis. 2022 Aug;54(8):997-1006. doi: 10.1016/j.dld.2021.10.010. Epub 2021 Nov 15.
6
Health-related quality of life in patients with compensated and decompensated liver cirrhosis.代偿期和失代偿期肝硬化患者的健康相关生活质量。
Eur J Intern Med. 2019 Dec;70:54-59. doi: 10.1016/j.ejim.2019.09.004. Epub 2019 Sep 14.
7
New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients.肝硬化的新概念:肝硬化患者肌肉减少症的临床意义。
Minerva Gastroenterol Dietol. 2013 Jun;59(2):173-86.
8
Impact of poor mental health in adult spinal deformity patients with poor physical function: a retrospective analysis with a 2-year follow-up.心理健康状况不佳对身体功能较差的成人脊柱畸形患者的影响:一项为期2年随访的回顾性分析
J Neurosurg Spine. 2017 Jan;26(1):116-124. doi: 10.3171/2016.5.SPINE151428. Epub 2016 Aug 19.
9
Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis.腹横肌厚度对肝硬化患者肌少症诊断的临床价值。
Clin Mol Hepatol. 2018 Sep;24(3):319-330. doi: 10.3350/cmh.2017.0077. Epub 2018 Apr 30.
10
Cirrhotic cardiomyopathy: does it contribute to chronic fatigue and decreased health-related quality of life in cirrhosis?肝硬化性心肌病:它是否会导致肝硬化患者出现慢性疲劳并降低与健康相关的生活质量?
Can J Gastroenterol. 2003 Sep;17(9):545-51. doi: 10.1155/2003/213213.

引用本文的文献

1
Advances in the diagnosis and management of clinically significant portal hypertension in cirrhosis: A narrative review.肝硬化中具有临床意义的门静脉高压症的诊断与管理进展:一篇叙述性综述。
World J Hepatol. 2025 Jun 27;17(6):104761. doi: 10.4254/wjh.v17.i6.104761.
2
A sex-oriented analysis concerning skeletal muscle quantity and quality and associations to quality of life in hospitalized patients with cirrhosis.肝硬化住院患者的骨骼肌量和质与生活质量的性别相关分析。
Health Qual Life Outcomes. 2024 Sep 12;22(1):78. doi: 10.1186/s12955-024-02295-2.
3
Hepatic immune regulation and sex disparities.
肝脏免疫调节与性别差异。
Nat Rev Gastroenterol Hepatol. 2024 Dec;21(12):869-884. doi: 10.1038/s41575-024-00974-5. Epub 2024 Sep 5.
4
Assessment of gnostic and stereognostic functions in patients with liver cirrhosis: A comparative study with healthy controls.评估肝硬化患者的直觉和触觉功能:与健康对照组的对比研究。
J Back Musculoskelet Rehabil. 2024;37(6):1685-1694. doi: 10.3233/BMR-240114.
5
Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution?肝硬化患者肌少症的快速简易评估:超声检查能否成为解决方案?
World J Gastroenterol. 2024 May 7;30(17):2287-2293. doi: 10.3748/wjg.v30.i17.2287.
6
Modular multimodal hospital-home chain physical activity rehabilitation programme (3M2H-PARP) in liver cancer: a protocol for a randomised controlled trial.模块化多模式医院-家庭链体力活动康复方案(3M2H-PARP)在肝癌中的应用:一项随机对照试验方案。
BMJ Open. 2024 May 21;14(5):e083228. doi: 10.1136/bmjopen-2023-083228.
7
Correlation between sarcopenia and cirrhosis: a meta-analysis.肌肉减少症与肝硬化之间的相关性:一项荟萃分析。
Front Nutr. 2024 Jan 10;10:1342100. doi: 10.3389/fnut.2023.1342100. eCollection 2023.
8
Sarcopenia and Mortality in Critically Ill COVID-19 Patients.危重症 COVID-19 患者的肌肉减少症与死亡率
Life (Basel). 2023 Dec 22;14(1):24. doi: 10.3390/life14010024.
9
Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis-Pathogenesis, Implications and Therapeutic Opportunities.失代偿期肝硬化的营养不良和肌肉减少症相关门静脉高压症的发病机制、影响及治疗机会
Nutrients. 2023 Dec 21;16(1):35. doi: 10.3390/nu16010035.
10
Sarcopenia in chronic viral hepatitis: From concept to clinical relevance.慢性病毒性肝炎中的肌肉减少症:从概念到临床意义
World J Hepatol. 2023 May 27;15(5):649-665. doi: 10.4254/wjh.v15.i5.649.